Pinés Corrales Pedro J, López Garrido M Pilar, Louhibi Rubio Lynda, Aznar Rodríguez Silvia, López Jiménez Luz M, Lamas Oliveira Cristina, Lozano García José J, Alfaro Martínez José J, Hernández López Antonio, Requejo Castillo Ramón, Escribano Martínez Julio, Botella Romero Francisco
Sección de Endocrinología y Nutrición, Complejo Hospitalario Universitario de Albacete, Albacete, España.
Endocrinol Nutr. 2011 Aug-Sep;58(7):341-6. doi: 10.1016/j.endonu.2011.05.002. Epub 2011 Jul 6.
MODY (maturity onset diabetes of the young) is a group of well-defined diseases clinically characterised by onset before age 25 years that does not require insulin treatment (at least initially) to prevent the formation of ketone bodies and autosomal dominant inheritance. Despite the importance of accurate classification, it is not always simple to catalogue the diagnosis of a young patient with diabetes, and genetic studies are often improperly used.
We describe the clinical features of patients negative for MODY2 and MODY3 and compared them to patients positive for these subtypes.
All patients with MODY3 had been diagnosed before age 25 years and required drug therapy for blood glucose control. MODY2 patients were diagnosed at the first laboratory workup either incidentally or as part of gestational diabetes screening. The clinical description of the 19 patients negative for MODY2 and MODY3 showed that only two patients presented a clinical picture consistent with MODY3 and one patient with MODY2.
Clinical features can be used for early exclusion of a MODY2 or MODY3 diagnosis and may reduce the need for genetic testing.
青年发病的成年型糖尿病(MODY)是一组明确的疾病,其临床特征为25岁前发病,不需要胰岛素治疗(至少在初始阶段)以预防酮体形成,且呈常染色体显性遗传。尽管准确分类很重要,但对年轻糖尿病患者进行诊断分类并不总是那么简单,而且基因研究常常被不当使用。
我们描述了MODY2和MODY3检测呈阴性的患者的临床特征,并将其与这些亚型检测呈阳性的患者进行比较。
所有MODY3患者均在25岁前被诊断出来,且需要药物治疗来控制血糖。MODY2患者在首次实验室检查时被偶然诊断出来,或者是作为妊娠期糖尿病筛查的一部分被诊断出来。19例MODY2和MODY3检测呈阴性的患者的临床描述显示,只有2例患者的临床表现符合MODY3,1例符合MODY2。
临床特征可用于早期排除MODY2或MODY3诊断,可能会减少基因检测的需求。